Comparison of the clinical courses of the opticospinal and conventional forms of multiple sclerosis in Japan

Internal Medicine

Volumn 44, Issue 9, 2005, Pages 934-938

  Osoegawa, Manabu ^a   Niino, Masaaki ^b   Tanaka, Masahito ^a   Kikuchi, Seiji ^b   Murai, Hiroyuki ^a   Fukazawa, Toshiyuki ^c   Minohara, Motozumi ^a   Miyagishi, Ryuji ^d   Taniwaki, Takayuki ^a   Tashiro, Kunio ^b   Kira, Jun Ichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Hokuyukai Neurology Hospital   (Japan)

^d Nishimaruyama Hospital   (Japan)

Author keywords

Conventional form; Multiple sclerosis; Opticospinal form; Progression

Indexed keywords

ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE DURATION; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; ONSET AGE; OPTIC NERVE DISEASE; PHYSICAL DISABILITY; QUANTITATIVE ANALYSIS; RELAPSE; SCORING SYSTEM; SEX DIFFERENCE; SPINAL CORD DISEASE; STATISTICAL SIGNIFICANCE;

ADULT; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OPTIC NERVE; RETROSPECTIVE STUDIES; SPINAL CORD; TIME FACTORS;

EID: 27844611247     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.44.934     Document Type: Article

References (16)

1. Kuroiwa Y, Igata A, Itahara K, Koshijima S, Tsubaki T. Nationwide survey of multiple sclerosis in Japan: clinical analysis of 1,084 cases. Neurology 25: 845-851, 1975.
2. Kira J, Kanai T, Nishimura Y, et al. Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann Neurol 40: 569-574, 1996.
3. Yamasaki K, Horiuchi I, Minohara M, et al. HLA-DPB1 *501-associated opticospinal multiple sclerosis. Clinical, neuroimaging and imummogenetic studies. Brain 122: 1689-1696, 1999.
4. Fukazawa T, Kikuchi S, Sasaki H, et al. The significance of oligoclonal bands in multiple sclerosis in Japan: relevance of immunogenetic backgrounds. J Neurol Sci 158: 209-214, 1998.
5. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33: 1444-1452, 1983.
6. Kira J. Multiple sclerosis in the Japanese population. Lancet Neurol 2: 117-127, 2003.
7. Ikuta F, Koga M, Takeda S, et al. Comparison of MS pathology between 70 American and 75 Japanese autopsy cases. In: Multiple Sclerosis East and West, Kyushu University Press, Kuroiwa Y, Kurland LT, Eds. Fukuoka, 1982: 297-306.
8. Tabira T, Tateishi J. Neuropathological features of MS In Japan. in: Multiple Sclerosis East and West, Kuroiwa Y, Kurland LT, Eds. Kyushu University Press, Fukuoka, 1982: 273-295.
9. Shibasaki H, McDonald WI, Kuroiwa Y. Racial modification of clinical picture of multiple sclerosis: Comparison between British and Japanese patients. J Neurol Sci 49: 253-271, 1981.
10. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 50: 121-127, 2001.
11. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 46: 907-911, 1996.
12. Confavreux C, Vukusic S, Moreau T, Adeleine P. Relapses and progression of disability in multiple sclerosis. N Engl J Med 343: 1430-1438, 2000.
13. Kaufman MD, Johnson SK, Moyer D, Bivens J, Norton HJ. Multiple sclerosis: severity and progression rate in African Americans compared with whites. Am J Phys Med Rehabil 82: 582-590, 2003.
14. Osuntokun BO. The pattern of neurological illness in tropical Africa. Experience at Ibadan, Nigeria. J Neurol Sci 12: 417-442, 1971.
15. Cabre P, Heinzlef O, Merle H, et al. MS and neuromyelitis optica in Martinique (French West Indies). Neurology 56: 507-514, 2001.
16. Lassmann H, Ransohoff RM. The CD4-Th1 model for multiple sclerosis: a critical re-appraisal. Trends Imummol 25: 132-137, 2004.